Oral Leukoplakia Clinical Trial
Official title:
A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
You have been asked to participate in this research study because you have or may have oral leukoplakia. Oral leukoplakia is described as a white patch or plaque on the oral mucosa (mouth) that will not rub off and cannot be removed by scraping, reversed by elimination of obvious irritants (things that cause redness and/or swelling) such as dentures (artificial replacment for missing teeth), or lesions as described that are diagnosed by your dentist.
Since oral leukoplakia may precede the development of cancer, using agents that may prevent cancer, called chemoprevention, may be useful. The purpose of this study is to determine whether taking a green tea preparation may have effects on your leukoplakia. It is hoped that these effects may reduce the subsequent risk of cancer in or around the area of leukoplakia. To assess for these effects, samples of the lining of your mouth will be obtained, and they will be analyzed looking for certain features (biomarkers). ;
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT05505539 -
Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia
|
Phase 1 | |
Completed |
NCT03682562 -
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
|
||
Completed |
NCT04153266 -
Oral Epithelial Dysplasia Informational Needs Questionnaire
|
||
Completed |
NCT04712929 -
Candida Associated Cytokines in Oral Leukoplakia
|
||
Completed |
NCT03031899 -
Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy
|
||
Terminated |
NCT00571558 -
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia
|
Phase 1 | |
Recruiting |
NCT06321003 -
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
|
||
Not yet recruiting |
NCT04732741 -
Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
|
||
Completed |
NCT00369174 -
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
|
Phase 2 | |
Completed |
NCT00099021 -
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
|
Phase 2 | |
Not yet recruiting |
NCT05727761 -
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
|
Phase 2 | |
Active, not recruiting |
NCT02581137 -
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
|
Phase 2 | |
Recruiting |
NCT05942794 -
Identification of Oral Lesions Through an Autofluorescence System
|
N/A | |
Completed |
NCT00330382 -
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
|
Phase 2 | |
Recruiting |
NCT05237960 -
Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
|
Phase 2 | |
Not yet recruiting |
NCT06256809 -
Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study
|
||
Completed |
NCT00951379 -
Pioglitazone for Oral Premalignant Lesions
|
Phase 2 | |
Recruiting |
NCT04251845 -
Evaluation of Effect of Topical Melatonin in Treatment of Oral Leukoplakia
|
N/A | |
Terminated |
NCT04079491 -
Intra and Extra Oral Inspection of Oral Mucosa
|
||
Recruiting |
NCT00767442 -
Least Invasive Nonlinear Light Microscopy
|
N/A |